Exercise as treatment for androgen deprivation therapy-associated physical dysfunction: Ready for prime time?

European Urology

Volumn 65, Issue 5, 2014, Pages 873-874

  Harrison, Michael R ^a   Jones, Lee W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABIRATERONE ACETATE; ANDROGEN; ENZALUTAMIDE; TESTOSTERONE;

ANDROGEN DEPRIVATION THERAPY; CARDIOTOXICITY; CASTRATION RESISTANT PROSTATE CANCER; EDITORIAL; HUMAN; KINESIOTHERAPY; PRIORITY JOURNAL; PROSTATE CANCER; RESISTANCE TRAINING;

ANDROGEN ANTAGONISTS; EXERCISE THERAPY; FATIGUE; HUMANS; MALE; PHYSICAL CONDITIONING, HUMAN; PHYSICAL FITNESS; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SEDENTARY LIFESTYLE;

EID: 84896397071     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.11.033     Document Type: Editorial

References (10)

1. C. Huggins, and C.V. Hodges Studies on prostatic cancer, I: the effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate Cancer Res 1 1941 293 297
2. N.L. Keating, A.J. O'Malley, and M.R. Smith Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer J Clin Oncol 24 2006 4448 4456
3. FDA drug safety communication: update to ongoing safety review of GnRH agonists and notification to manufacturers of GnRH agonists to add new safety information to labeling regarding increased risk of diabetes and certain cardiovascular diseases. US Food and Drug Administration Web site. http://www.fda.gov/Drugs/DrugSafety/ucm229986.htm. Accessed October 20, 2010.
4. L. Bourke, S. Gilbert, and R. Hooper et al. Lifestyle changes for improving disease specific quality of life in sedentary men on long term androgen deprivation therapy for advanced prostate cancer: a randomised controlled trial Eur Urol 65 2014 865 872
5. D.A. Galvao, N. Spry, and J. Denham et al. A multicentre year-long randomized controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR Eur Urol 65 2014 856 864
6. R.J. Segal, R.D. Reid, and K.S. Courneya et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer J Clin Oncol 27 2009 344 351
7. D.A. Galvao, D.R. Taaffe, N. Spry, D. Joseph, and R.U. Newton Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial J Clin Oncol 28 2010 340 347
8. C.M. Alfano, P.A. Ganz, J.H. Rowland, and E.E. Hahn Cancer survivorship and cancer rehabilitation: revitalizing the link J Clin Oncol 30 2012 904 906
9. H.I. Scher, K. Fizazi, and F. Saad et al. Increased survival with enzalutamide in prostate cancer after chemotherapy N Engl J Med 367 2012 1187 1197
10. C.J. Ryan, M.R. Smith, and J.S. de Bono et al. Abiraterone in metastatic prostate cancer without previous chemotherapy N Engl J Med 368 2013 138 148